Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    No changes were detected in the provided changes data. The page content remains as published for the study details.
    Difference
    0.1%
    Check dated 2026-05-22T07:54:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, representing a new build of the site's interface.
    Difference
    0.0%
    Check dated 2026-05-14T23:16:03.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision text on the page now shows v3.5.3, replacing v3.5.2. This reflects a minor version update in the site’s revision history.
    Difference
    0.0%
    Check dated 2026-04-30T16:43:20.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.2, replacing v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T09:55:36.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Core study information appears unchanged; updates are limited to metadata such as the last updated date.
    Difference
    0.1%
    Check dated 2026-04-01T22:38:57.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added the condition Myelodysplastic/myeloproliferative neoplasm and removed Myeloproliferative neoplasm from the Conditions list; page revision updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:05:25.000Z thumbnail image

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.